🇺🇸 United States Medical Licensing Examination (USMLE) · subject

United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK) Syllabus

The Internal Medicine and Clinical Knowledge (Step 2 CK) syllabus for United States Medical Licensing Examination (USMLE) in full: 6 chapters, 30 topics and 5 sub-topics, every one listed below, plus 67 Internal Medicine and Clinical Knowledge (Step 2 CK) flashcards with answers.

6Chapters
30Topics
5Sub-topics
67Flashcards

Internal Medicine and Clinical Knowledge (Step 2 CK) syllabus: all 6 chapters

Expand any chapter to see its topics and sub-topics.

  1. Cardiovascular Disorders

    5 topics
    • Acute coronary syndromes
      • STEMI and NSTEMI management
      • Reperfusion strategies
    • Heart failure and arrhythmias
      • Systolic vs diastolic failure
      • Atrial fibrillation and SVT
    • Hypertension and dyslipidemia
    • Valvular and pericardial disease
    • Vascular and aortic emergencies
  2. Pulmonary and Critical Care

    5 topics
    • Respiratory failure and ARDS
    • Obstructive airway exacerbations
    • Pulmonary embolism workup
    • Pleural disease and effusions
    • Sepsis and shock management
  3. Gastroenterology and Hepatology

    5 topics
    • GI bleeding evaluation
    • Inflammatory bowel disease management
    • Liver disease and cirrhosis complications
    • Pancreatitis and biliary disease
    • Functional GI and screening
  4. Endocrinology and Renal Medicine

    5 topics
    • Diabetes and metabolic emergencies
      • DKA and HHS
    • Thyroid and adrenal management
    • Fluid, electrolyte, and acid-base correction
    • Acute kidney injury and dialysis indications
    • Chronic kidney disease management
  5. Infectious Disease and Hematology-Oncology

    5 topics
    • Antimicrobial selection and stewardship
    • HIV and opportunistic infections
    • Healthcare-associated infections
    • Oncologic emergencies
    • Anemia and coagulopathy workup
  6. Rheumatology and Neurology

    5 topics
    • Systemic autoimmune disease
    • Inflammatory and degenerative arthritis
    • Stroke and TIA management
    • Seizure and headache evaluation
    • Neuromuscular and movement disorders

United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK) flashcards — 67 questions with answers

  1. What are the three serial troponin findings and ECG criteria that distinguish STEMI from NSTEMI in acute coronary syndrome?

    STEMI: ST elevation >=1mm in >=2 contiguous limb leads or >=2mm in precordial leads (or new LBBB) PLUS elevated troponin. NSTEMI: elevated troponin WITHOUT persistent ST elevation (may show ST depression/T-wave inversion). Unstable angina: ischemic symptoms with NO troponin rise.

  2. What is the immediate initial pharmacologic management ('MONA-B' plus) for a patient presenting with acute coronary syndrome?

    Aspirin (chewed, 162-325 mg), a P2Y12 inhibitor (e.g., ticagrelor/clopidogrel), anticoagulation (heparin), high-intensity statin, beta-blocker (if no contraindication), nitrates for pain, and oxygen only if SpO2 <90%. STEMI requires emergent reperfusion (PCI within 90 min, or fibrinolysis if PCI unavailable within 120 min).

  3. In acute STEMI, which coronary artery occlusion corresponds to inferior leads (II, III, aVF), and what management precaution does it demand?

    Right coronary artery (most commonly). Suspect right ventricular infarction-obtain right-sided leads (V4R). Avoid nitrates and other preload-reducing agents because the RV is preload-dependent; treat hypotension with IV fluids.

  4. How is the New York Heart Association (NYHA) functional classification of heart failure defined (Classes I-IV)?

    Class I: no symptoms with ordinary activity. Class II: symptoms with ordinary activity. Class III: symptoms with less-than-ordinary activity. Class IV: symptoms at rest.

  5. Which four drug classes are guideline-directed therapy proven to reduce mortality in heart failure with reduced ejection fraction (HFrEF)?

    (1) ARNI (or ACE inhibitor/ARB), (2) beta-blocker (carvedilol, metoprolol succinate, or bisoprolol), (3) mineralocorticoid receptor antagonist (spironolactone/eplerenone), and (4) SGLT2 inhibitor. Diuretics relieve congestion but do not reduce mortality.

  6. What is the first-line management of unstable atrial fibrillation (hypotension, ischemia, pulmonary edema) versus stable AF?

    Unstable: immediate synchronized cardioversion. Stable: rate control (beta-blocker or non-dihydropyridine CCB) and anticoagulation based on CHA2DS2-VASc score; rhythm control as needed.

  7. What is the CHA2DS2-VASc score and the threshold for recommending oral anticoagulation in atrial fibrillation?

    CHF (1), Hypertension (1), Age >=75 (2), Diabetes (1), Stroke/TIA/thromboembolism (2), Vascular disease (1), Age 65-74 (1), Sex category female (1). Anticoagulate men with score >=2 and women >=3; consider it at >=1 (men)/>=2 (women).

  8. What blood pressure threshold defines hypertension by ACC/AHA 2017 guidelines, and what are the stages?

    Normal <120/<80; Elevated 120-129/<80; Stage 1: 130-139 or 80-89; Stage 2: >=140 or >=90. Hypertensive crisis: >180/>120.

  9. What is the difference between a hypertensive urgency and a hypertensive emergency, and how does management differ?

    Both have BP >180/120. Emergency = acute target-organ damage (encephalopathy, stroke, MI, aortic dissection, pulmonary edema, AKI, eclampsia) requiring IV agents to lower BP ~10-20% in the first hour. Urgency = no end-organ damage; lower BP gradually over 24-48h with oral agents.

  10. According to ACC/AHA, which patient groups warrant high-intensity statin therapy for dyslipidemia?

    (1) Clinical ASCVD; (2) LDL >=190 mg/dL; (3) diabetics aged 40-75 with high risk; (4) 10-year ASCVD risk >=20%. High-intensity statins (atorvastatin 40-80 mg, rosuvastatin 20-40 mg) lower LDL by >=50%.

  11. What murmur characterizes aortic stenosis, and what is the management for symptomatic severe AS?

    Crescendo-decrescendo (ejection) systolic murmur at the right upper sternal border radiating to the carotids, with delayed/diminished carotid upstroke (pulsus parvus et tardus). Symptomatic severe AS (angina, syncope, heart failure) requires aortic valve replacement (SAVR or TAVR); avoid vasodilators/nitrates.

  12. How do you distinguish acute pericarditis from STEMI on ECG and exam?

    Pericarditis: diffuse (not territorial) ST elevation with PR depression, pleuritic chest pain relieved by sitting forward, and a friction rub. STEMI: regional ST elevation with reciprocal changes. Pericarditis is treated with NSAIDs + colchicine.

  13. What is Beck's triad of cardiac tamponade, and what is the definitive treatment?

    Hypotension, jugular venous distention, and muffled heart sounds. Also pulsus paradoxus (>10 mmHg inspiratory drop in SBP) and electrical alternans. Definitive treatment: urgent pericardiocentesis.

  14. What clinical features and management define acute aortic dissection (Stanford classification)?

    Sudden tearing chest/back pain, BP differential between arms, widened mediastinum. Stanford A (ascending aorta) needs emergent surgery; Stanford B (descending only) is managed medically with rapid HR/BP control (IV beta-blocker first, e.g., esmolol/labetalol, then nitroprusside) targeting SBP 100-120 and HR <60.

  15. What is the classic presentation and immediate management of a ruptured abdominal aortic aneurysm (AAA)?

    Triad of hypotension, pulsatile abdominal mass, and abrupt abdominal/back/flank pain. Unstable patients go straight to emergent surgical repair; stable patients can have CT angiography. AAA repair is indicated at diameter >=5.5 cm, rapid growth, or symptoms.

  16. How are acute respiratory failure types I and II distinguished by ABG?

    Type I (hypoxemic): PaO2 <60 mmHg with normal/low PaCO2 (e.g., pneumonia, ARDS, PE). Type II (hypercapnic): PaCO2 >50 mmHg with respiratory acidosis (e.g., COPD, neuromuscular weakness, drug overdose).

  17. What are the Berlin criteria for diagnosing ARDS?

    (1) Acute onset within 1 week of insult; (2) bilateral pulmonary infiltrates on imaging not fully explained by effusion/atelectasis; (3) not fully explained by cardiac failure/fluid overload (PCWP <=18 or no LA hypertension); (4) hypoxemia by PaO2/FiO2: mild 200-300, moderate 100-200, severe <100 (on PEEP >=5).

  18. What is the lung-protective ventilation strategy for ARDS?

    Low tidal volume (6 mL/kg ideal body weight), plateau pressure <30 cmH2O, permissive hypercapnia, adequate PEEP, and prone positioning for severe ARDS (PaO2/FiO2 <150). This strategy reduces mortality.

  19. What is the stepwise treatment of an acute COPD exacerbation?

    Inhaled short-acting bronchodilators (albuterol + ipratropium), systemic corticosteroids (e.g., prednisone 40 mg x5 days), antibiotics if increased dyspnea + sputum volume + purulence, controlled oxygen targeting SpO2 88-92%, and noninvasive positive-pressure ventilation (BiPAP) for respiratory acidosis (pH <7.35).

  20. What defines status asthmaticus and how is a severe asthma exacerbation managed?

    Severe asthma unresponsive to initial bronchodilators. Management: continuous/repeated nebulized albuterol + ipratropium, systemic corticosteroids, IV magnesium sulfate, oxygen; consider intubation for fatigue, silent chest, or rising PaCO2 (a normalizing/rising CO2 in a tiring asthmatic signals impending respiratory failure).

Show the other 47 Internal Medicine and Clinical Knowledge (Step 2 CK) flashcards
  1. What is the Wells criteria-based diagnostic pathway for suspected pulmonary embolism?

    Low/intermediate probability (Wells <=4): obtain D-dimer-if negative, PE excluded; if positive, do CT pulmonary angiography. High probability (Wells >4): go directly to CTPA. Use V/Q scan if contrast/contraindication to CT (e.g., renal failure).

  2. What is the treatment of acute pulmonary embolism, including the indication for thrombolysis?

    Anticoagulation (LMWH/DOAC, or heparin if unstable). Thrombolysis (e.g., tPA) is indicated for massive PE with hemodynamic instability (hypotension). Submassive PE with RV strain may be considered for thrombolysis/embolectomy. IVC filter if anticoagulation is contraindicated.

  3. How does Light's criteria differentiate exudative from transudative pleural effusions?

    Exudate if ANY of: pleural/serum protein ratio >0.5; pleural/serum LDH ratio >0.6; or pleural LDH >2/3 the upper limit of serum LDH. Transudates (CHF, cirrhosis, nephrotic syndrome) meet none; exudates suggest infection, malignancy, or PE.

  4. What pleural fluid findings indicate a complicated parapneumonic effusion/empyema requiring chest tube drainage?

    Pleural fluid pH <7.2, glucose <60 mg/dL, positive Gram stain/culture, or frank pus. These require tube thoracostomy drainage in addition to antibiotics.

  5. What are the Sepsis-3 definitions of sepsis and septic shock?

    Sepsis: life-threatening organ dysfunction (SOFA increase >=2) due to dysregulated host response to infection. Septic shock: sepsis with vasopressor requirement to maintain MAP >=65 mmHg AND serum lactate >2 mmol/L despite adequate fluid resuscitation.

  6. What are the key components of the initial sepsis resuscitation ('Hour-1') bundle?

    Measure lactate, obtain blood cultures before antibiotics, give broad-spectrum antibiotics, administer 30 mL/kg crystalloid for hypotension or lactate >=4, and start vasopressors (norepinephrine first-line) if hypotensive during/after fluids to maintain MAP >=65.

  7. How are the four main shock types distinguished by cardiac output, SVR, and preload (CVP/PCWP)?

    Hypovolemic: low CO, high SVR, low preload. Cardiogenic: low CO, high SVR, high preload. Obstructive (PE/tamponade): low CO, high SVR, variable/high preload. Distributive (septic/anaphylactic): high CO, low SVR, low preload.

  8. What is the initial approach to acute upper GI bleeding and the role of risk stratification?

    Resuscitate (two large-bore IVs, fluids, transfuse to Hgb ~7 g/dL restrictive threshold), IV PPI, and upper endoscopy within 24h. For suspected variceal bleed add octreotide and prophylactic antibiotics (ceftriaxone). Glasgow-Blatchford score identifies low-risk patients for outpatient management.

  9. How do you differentiate upper from lower GI bleeding and what initial test helps?

    Upper GI bleed (proximal to ligament of Treitz): hematemesis, melena, elevated BUN:Cr ratio (>20-30). Lower GI bleed: hematochezia. A nasogastric aspirate or upper endoscopy can confirm upper source; melena suggests upper but can be right colon.

  10. What are the key distinguishing features between Crohn disease and ulcerative colitis?

    Crohn: transmural, skip lesions anywhere mouth-to-anus (terminal ileum common), non-caseating granulomas, fistulae/strictures, cobblestoning. UC: continuous mucosal inflammation from rectum proximally, limited to colon, crypt abscesses, increased colon cancer risk, associated with PSC; curable by colectomy.

  11. What is the general treatment escalation ('step-up') for inflammatory bowel disease?

    5-ASA (mesalamine, mainly UC) -> corticosteroids for flares -> immunomodulators (azathioprine, 6-MP, methotrexate) -> biologics (anti-TNF like infliximab, anti-integrin vedolizumab, anti-IL-12/23 ustekinumab). Surgery is curative for UC.

  12. What is the diagnostic workup and management of spontaneous bacterial peritonitis (SBP) in cirrhosis?

    Diagnostic paracentesis showing ascitic fluid PMN count >=250 cells/mm3. Treat empirically with IV third-generation cephalosporin (cefotaxime) plus IV albumin (to reduce renal failure/mortality). Give long-term fluoroquinolone prophylaxis after an episode.

  13. What is hepatic encephalopathy and its first-line treatment?

    Reversible neuropsychiatric dysfunction from accumulated nitrogenous toxins (ammonia) in liver failure, often with asterixis. First-line: lactulose (titrated to 2-3 soft stools/day); add rifaximin for recurrence. Identify and treat precipitants (GI bleed, infection, constipation, electrolyte disturbance).

  14. How is the severity and gradient of ascites assessed, and what does SAAG indicate?

    Serum-ascites albumin gradient (SAAG) = serum albumin - ascites albumin. SAAG >=1.1 g/dL indicates portal hypertension (cirrhosis, heart failure, Budd-Chiari). SAAG <1.1 suggests non-portal causes (malignancy, TB, pancreatitis, nephrotic syndrome).

  15. What are the diagnostic criteria for acute pancreatitis (2 of 3) and the main management?

    Diagnosis requires >=2 of: (1) characteristic epigastric pain radiating to back; (2) lipase/amylase >=3x upper limit normal; (3) imaging findings. Management: aggressive IV fluids, analgesia, early enteral nutrition; most common causes are gallstones and alcohol.

  16. What is Charcot's triad and Reynolds' pentad in acute cholangitis, and the management?

    Charcot's triad: fever, RUQ pain, jaundice. Reynolds' pentad adds hypotension and altered mental status (suppurative cholangitis). Management: IV antibiotics, fluids, and urgent biliary decompression via ERCP.

  17. What are the Rome IV-based diagnostic features and management of irritable bowel syndrome (IBS)?

    Recurrent abdominal pain >=1 day/week for 3 months associated with defecation and/or change in stool frequency/form, without alarm features. Management is symptom-based: fiber/antispasmodics, IBS-C (linaclotide/lubiprostone), IBS-D (loperamide, rifaximin); evaluate alarm features (weight loss, bleeding, anemia, age >50).

  18. At what age and intervals is average-risk colorectal cancer screening recommended, and what are the options?

    Begin at age 45 (USPSTF). Options: colonoscopy every 10 years, FIT annually, FIT-DNA every 1-3 years, CT colonography every 5 years, or flexible sigmoidoscopy every 5 years. Continue through age 75 (individualize 76-85).

  19. What distinguishes diabetic ketoacidosis (DKA) from hyperosmolar hyperglycemic state (HHS)?

    DKA (usually T1DM): glucose >250, pH <7.3, bicarbonate <18, positive ketones, anion gap acidosis. HHS (usually T2DM): glucose often >600, osmolality >320, minimal/no ketones, pH >7.3, profound dehydration, altered mental status. Both treated with IV fluids, insulin, and potassium repletion.

  20. What is the correct sequence and key safety points of DKA management?

    IV isotonic fluids first; check potassium-if K <3.3, hold insulin and replete K first; start IV insulin infusion; add potassium when K <5.3 with urine output; switch fluids to D5-containing when glucose ~200; continue insulin until anion gap closes and overlap with subcutaneous insulin before stopping the drip.

  21. How is primary versus secondary hyperthyroidism interpreted, and what is the treatment of thyroid storm?

    Primary hyperthyroidism: low TSH, high free T4 (e.g., Graves). Thyroid storm treatment order: beta-blocker (propranolol), thionamide (PTU preferred), then iodine (Lugol's) at least 1 hour after thionamide, plus glucocorticoids; treat precipitant and provide supportive care.

  22. How do you diagnose primary adrenal insufficiency (Addison) and manage adrenal crisis?

    Diagnosis: low morning cortisol with inappropriately high ACTH and inadequate response to cosyntropin (ACTH) stimulation test; hyponatremia + hyperkalemia. Adrenal crisis treatment: immediate IV hydrocortisone, aggressive IV normal saline, and dextrose; do not delay steroids for testing.

  23. How do you calculate the corrected sodium in hyperglycemia and the free water deficit in hypernatremia?

    Corrected Na = measured Na + 1.6 (or 2.4) x [(glucose - 100)/100]. Free water deficit = total body water x [(serum Na/140) - 1], where TBW = 0.6 x weight(kg) in men (0.5 in women). Correct chronic hypernatremia slowly (<10-12 mEq/L per 24h).

  24. What is the danger of overly rapid correction of hyponatremia, and the safe correction rate?

    Overly rapid correction risks osmotic demyelination syndrome (central pontine myelinolysis). Limit correction to <=8 mEq/L per 24 hours (more conservative, ~6, in high-risk patients). For severe symptomatic hyponatremia, give 3% hypertonic saline boluses to raise Na ~4-6 mEq acutely.

  25. How do you interpret a primary metabolic acidosis using the anion gap and Winter's formula?

    Anion gap = Na - (Cl + HCO3); normal ~12. High anion gap acidosis (MUDPILES). Winter's formula predicts respiratory compensation: expected PaCO2 = 1.5 x HCO3 + 8 (+/-2). Measured PaCO2 above expected = concurrent respiratory acidosis; below = concurrent respiratory alkalosis.

  26. How are the categories of acute kidney injury (prerenal, intrinsic, postrenal) distinguished by FENa and urine findings?

    Prerenal: FENa <1%, BUN:Cr >20, bland sediment, concentrated urine (Uosm >500). Intrinsic (ATN): FENa >2%, muddy brown granular casts, isosthenuria. Postrenal: obstruction on imaging (hydronephrosis). FEurea <35% is useful for prerenal if on diuretics.

  27. What are the emergent (AEIOU) indications for dialysis in acute kidney injury?

    Acidosis (refractory metabolic), Electrolytes (refractory hyperkalemia), Intoxications (dialyzable toxins-methanol, ethylene glycol, salicylates, lithium), Overload (refractory volume overload/pulmonary edema), Uremia (encephalopathy, pericarditis, bleeding).

  28. How is chronic kidney disease staged by GFR, and what are the cornerstones of management?

    G1 >=90, G2 60-89, G3a 45-59, G3b 30-44, G4 15-29, G5 <15 (with albuminuria categories A1-A3). Management: ACE inhibitor/ARB for proteinuria, SGLT2 inhibitor, BP and glycemic control, manage anemia (EPO/iron), mineral-bone disease (phosphate binders, vitamin D), and avoid nephrotoxins.

  29. What is the difference between empiric and definitive (de-escalation) antimicrobial therapy in stewardship?

    Empiric therapy: broad-spectrum coverage started before culture results based on likely pathogens/site. Definitive therapy: narrow the spectrum once culture and susceptibility data return (de-escalation), choosing the narrowest effective agent for the shortest effective duration to limit resistance and toxicity.

  30. At what CD4 count do major opportunistic infections occur in HIV, and what prophylaxis is given?

    CD4 <200: Pneumocystis jirovecii pneumonia-prophylax with TMP-SMX. CD4 <100: Toxoplasma (also TMP-SMX). CD4 <50: Mycobacterium avium complex (historically azithromycin, now often deferred with ART) and CMV retinitis. Start antiretroviral therapy in all HIV patients.

  31. What is the empiric treatment and key diagnostic of Pneumocystis jirovecii pneumonia (PCP)?

    Presents with subacute dyspnea, dry cough, hypoxia, and elevated LDH; diffuse bilateral interstitial infiltrates. Treat with TMP-SMX; add adjunctive corticosteroids if PaO2 <70 mmHg or A-a gradient >=35 mmHg. Diagnosis via induced sputum/BAL with silver stain or PCR.

  32. How are hospital-acquired (HAP) and ventilator-associated pneumonia (VAP) defined and treated?

    HAP: pneumonia >=48h after admission; VAP: >=48h after intubation. Empiric therapy must cover MRSA (vancomycin/linezolid) and Pseudomonas (e.g., piperacillin-tazobactam, cefepime), with double anti-pseudomonal coverage if high resistance risk or septic shock.

  33. What is the diagnostic approach and treatment for Clostridioides difficile infection?

    Diagnose with stool PCR/toxin testing in patients with >=3 unformed stools/24h. First-line treatment: oral vancomycin or fidaxomicin (oral metronidazole only if non-severe and alternatives unavailable). Stop the inciting antibiotic; fulminant cases need oral vancomycin + IV metronidazole +/- surgery.

  34. What is tumor lysis syndrome, its lab findings, and management?

    Massive tumor cell breakdown (often after chemo of high-grade lymphoma/leukemia) causing hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia, risking AKI and arrhythmia. Management: aggressive IV hydration, rasburicase (or allopurinol for prophylaxis), and treat electrolyte abnormalities.

  35. What is the presentation and emergent management of malignant spinal cord compression?

    Back pain (often worse when lying down), progressive weakness, sensory level, and bowel/bladder dysfunction in a cancer patient. Give immediate IV dexamethasone and obtain urgent whole-spine MRI, followed by radiation oncology/neurosurgery for definitive decompression.

  36. How is anemia classified by MCV, with key examples in each category?

    Microcytic (MCV <80): iron deficiency, thalassemia, anemia of chronic disease (late), sideroblastic. Normocytic (80-100): acute blood loss, hemolysis, anemia of chronic disease, CKD. Macrocytic (MCV >100): B12/folate deficiency (megaloblastic), alcohol, liver disease, hypothyroidism, drugs.

  37. How do iron studies differentiate iron deficiency anemia from anemia of chronic disease?

    Iron deficiency: low ferritin, low serum iron, HIGH TIBC, low transferrin saturation. Anemia of chronic disease: normal/high ferritin, low serum iron, LOW/normal TIBC, often normal/low transferrin saturation due to iron sequestration.

  38. What lab pattern identifies disseminated intravascular coagulation (DIC)?

    Prolonged PT and aPTT, low fibrinogen, elevated D-dimer/fibrin degradation products, and thrombocytopenia, with schistocytes on smear. Treat the underlying cause; support with platelets, FFP, and cryoprecipitate (for low fibrinogen) as needed for bleeding.

  39. What are the diagnostic features and first-line treatment of systemic lupus erythematosus (SLE)?

    Multisystem autoimmune disease with malar rash, arthritis, serositis, nephritis, cytopenias; positive ANA (sensitive) and anti-dsDNA/anti-Smith (specific). Monitor disease with complement (C3/C4) and dsDNA. Treatment: hydroxychloroquine for all, with corticosteroids/immunosuppressants for organ involvement (e.g., lupus nephritis).

  40. How is giant cell (temporal) arteritis diagnosed and managed urgently?

    Older patient with new headache, jaw claudication, scalp tenderness, visual changes, and markedly elevated ESR/CRP, often with polymyalgia rheumatica. Start high-dose corticosteroids IMMEDIATELY (do not wait for biopsy) to prevent irreversible blindness; confirm with temporal artery biopsy.

  41. What synovial fluid features distinguish inflammatory, septic, and crystal arthritis?

    Non-inflammatory: WBC <2,000. Inflammatory: WBC 2,000-50,000. Septic: WBC >50,000 (often >75,000), high PMNs, positive Gram stain/culture. Gout: negatively birefringent needle-shaped (monosodium urate) crystals; pseudogout: positively birefringent rhomboid (calcium pyrophosphate) crystals.

  42. How is rheumatoid arthritis distinguished from osteoarthritis clinically and serologically?

    RA: symmetric inflammatory polyarthritis of MCP/PIP/wrists with morning stiffness >1h, positive RF and anti-CCP, elevated ESR/CRP, erosions on X-ray; spares DIPs. OA: asymmetric, weight-bearing/DIP joints, brief stiffness, no systemic inflammation, osteophytes and joint-space narrowing on X-ray.

  43. What is the time-sensitive treatment of acute ischemic stroke, including the tPA and thrombectomy windows?

    IV thrombolysis (alteplase/tenecteplase) within 4.5 hours of symptom onset after excluding hemorrhage with non-contrast CT. Mechanical thrombectomy for large-vessel occlusion up to 24 hours in selected patients with favorable perfusion imaging. Maintain permissive hypertension unless giving tPA (then BP <185/110).

  44. How do you differentiate a TIA from a stroke, and what is secondary prevention?

    TIA: transient neurologic deficit from ischemia WITHOUT acute infarction on imaging (deficits typically resolve within an hour). Stroke: deficit with infarction. Secondary prevention: antiplatelet therapy (aspirin, or short-term dual antiplatelet for high-risk TIA/minor stroke), high-intensity statin, BP control, and carotid endarterectomy if stenosis 70-99% symptomatic.

  45. What defines status epilepticus and what is the stepwise treatment?

    Continuous seizure >=5 minutes or recurrent seizures without recovery between them. Step 1: IV benzodiazepine (lorazepam). Step 2: IV antiseizure agent (levetiracetam, fosphenytoin, or valproate). Step 3 (refractory): anesthetic infusion (midazolam, propofol) with intubation; check glucose and treat reversible causes.

  46. What headache features are 'red flags' requiring urgent imaging?

    Thunderclap (worst-ever, sudden) headache, focal neurologic deficit, papilledema, headache with fever/neck stiffness, onset after age 50, immunosuppression/cancer, headache worse with Valsalva/positional, or progressive worsening. A thunderclap headache mandates CT and possibly LP to rule out subarachnoid hemorrhage.

  47. How is Parkinson disease characterized and treated, and what distinguishes essential tremor?

    Parkinson: bradykinesia plus resting (pill-rolling) tremor, cogwheel rigidity, and postural instability; treat with levodopa-carbidopa (or dopamine agonists). Essential tremor: bilateral ACTION/postural tremor improved by alcohol, often familial, treated with propranolol or primidone-no rest tremor or rigidity.

United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK) FAQ

What is in the United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK) syllabus?

United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK) is split into 6 chapters: Cardiovascular Disorders, Pulmonary and Critical Care, Gastroenterology and Hepatology, Endocrinology and Renal Medicine, Infectious Disease and Hematology-Oncology and Rheumatology and Neurology. Together they contain 30 topics and 5 sub-topics.

How many chapters are in United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK)?

6 chapters, containing 30 topics and 5 sub-topics. The largest chapter is Cardiovascular Disorders, with 5 topics.

Are there flashcards for United States Medical Licensing Examination (USMLE) Internal Medicine and Clinical Knowledge (Step 2 CK)?

Yes — a 67-card Internal Medicine and Clinical Knowledge (Step 2 CK) deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.